Table 2.
Demographic and clinical characteristics of subjects.
| Total N = 157 |
Spontaneous resolution N = 62 (39%) |
Chronic infection N = 95 (61%) |
p value (Chi-squared test unless otherwise noted) |
|
|---|---|---|---|---|
| Age, mean (SD) [range], years | 55.9 (8.2) [25, 81] |
55.7 (8.7) [25, 77] |
55.9 (7.8) [35, 81] |
0.87 (two-sample t-test) |
| Gender, number (%) | 0.44 | |||
| Male | 132 (84%) | 54 (87%) | 78 (82%) | |
| Female | 23 (15%) | 8 (13%) | 15 (16%) | |
| Trans | 2 (1%) | 0 | 2 (2%) | |
| Ethnicity, number (%) | 0.53 | |||
| Not Hispanic | 126 (80%) | 48 (77%) | 78 (82%) | |
| Hispanic | 20 (13%) | 10 (16%) | 10 (11%) | |
| Mixed | 6 (4%) | 3 (5%) | 3 (3%) | |
| Missing | 5 (3%) | 1 (2%) | 4 (4%) | |
| Self-identified race, number (%) | 0.01 | |||
| Caucasian | 84 (54%) | 36 (58%) | 48 (51%) | |
| Black | 43 (27%) | 8 (13%) | 35 (37%) | |
| Other or mixed | 14 (9%) | 7 (11%) | 7 (7%) | |
| Missing | 16 (10%) | 11 (18%) | 5 (5%) | |
| HIV status, number (%) | 0.26 | |||
| Infected | 42 (27%) | 13 (21%) | 29 (31%) | |
| Not infected | 115 (73%) | 49 (79%) | 66 (69%) | |
| HCG genotype, number (%) | NA | |||
| 1 | NA | NA | 67 (71%) | |
| 2 | NA | NA | 9 (10%) | |
| 3 | NA | NA | 11 (12%) | |
| 4 | NA | NA | 4 (4%) | |
| Unknown | NA | NA | 4 (4%) | |
| HCV treatment, number (%) | NA | |||
| SVR | NA | NA | 23 (24%) | |
| NR | NA | NA | 7 (7%) | |
| Not treated | NA | NA | 65 (68%) |
NA: not available.